Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Receivables: 2016-2024

Historic Receivables for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $253.5 million.

  • Collegium Pharmaceutical's Receivables rose 2.40% to $233.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $929.2 million, marking a year-over-year increase of 21.22%. This contributed to the annual value of $253.5 million for FY2024, which is 41.23% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Receivables stood at $253.5 million for FY2024, which was up 41.23% from $179.5 million recorded in FY2023.
  • In the past 5 years, Collegium Pharmaceutical's Receivables registered a high of $253.5 million during FY2024, and its lowest value of $83.3 million during FY2020.
  • For the 3-year period, Collegium Pharmaceutical's Receivables averaged around $205.4 million, with its median value being $183.1 million (2022).
  • Per our database at Business Quant, Collegium Pharmaceutical's Receivables surged by 73.01% in 2022 and then fell by 1.96% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's Receivables (Yearly) stood at $83.3 million in 2020, then rose by 27.03% to $105.8 million in 2021, then spiked by 73.01% to $183.1 million in 2022, then declined by 1.96% to $179.5 million in 2023, then skyrocketed by 41.23% to $253.5 million in 2024.